Burton I. Korelitz

Burton I. Korelitz's AcademicInfluence.com Rankings

Burton I. Korelitz

Philosophy

#8227

World Rank

#11566

Historical Rank

Logic

#5262

World Rank

#6647

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Burton I. Korelitz's Degrees

Doctorate Medicine Columbia University

Why Is Burton I. Korelitz Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Burton I. Korelitz's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. (1980) (984)
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine (2005) (765)
6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. (1989) (720)
Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. (2004) (444)
Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study (2000) (265)
Surveillance in the routine management of ulcerative colitis: the predictive value of low-grade dysplasia. (1992) (187)
Pregnancy in inflammatory bowel disease: Effect of sulfasalazine and corticosteroids on fetal outcome (1981) (165)
Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease (1998) (151)
Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome. (1981) (150)
Long-term experience with 6-mercaptopurine in the treatment of Crohn's disease. (1993) (148)
Inflammatory bowel disease and pregnancy. (1998) (147)
Nature and course of pancreatitis caused by 6-mercaptopurine in the treatment of inflammatory bowel disease. (1986) (147)
Favorable effect of 6-Mercaptopurine on fistulae of Crohn's disease (2005) (133)
Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine (1999) (129)
The course of nonspecific ulcerative colitis: review of twenty years' experience and late results. (1957) (124)
The course of inflammatory bowel disease during pregnancy and postpartum. (1981) (121)
Abnormalities of uterine cervix in women with inflammatory bowel disease. (2006) (121)
Activation of c-Ki-ras in human gastrointestinal dysplasias determined by direct sequencing of polymerase chain reaction products. (1990) (113)
The role of leukopenia in the 6-mercaptopurine-induced remission of refractory Crohn's disease. (1994) (113)
Carcinoma arising in anorectal fistulas of Crohn's disease (1998) (110)
The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome. (1984) (110)
Recurrent regional ileitis after ileostomy and colectomy for granulomatous colitis. (1972) (106)
Post-operative prophylaxis with 6-MP, 5-ASA or placebo in Crohn's disease: A 2 year multicenter trial* (1998) (99)
Anorectal Crohn's disease: definitive surgery for fistulas and recurrent abscesses. (1980) (98)
The therapeutic efficacy of 6-mercaptopurine in refractory ulcerative colitis. (1990) (95)
Crohn's disease in endoscopic biopsies of the gastric antrum and duodenum. (1981) (94)
Microgranulomas in grossly normal rectal mucosa in Crohn's disease. (1977) (91)
Cumulative Experience With Short- and Long-Term Toxicity to 6-Mercaptopurine in the Treatment of Crohn's Disease and Ulcerative Colitis (2003) (88)
Rectal biopsy in patients with Crohn's disease. Normal mucosa on sigmoidoscopic examination. (1977) (83)
Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents. (2016) (82)
Optimum duration of treatment with 6-mercaptopurine for Crohn's disease (1999) (79)
Anal skin tags in inflammatory bowel disease: New observations and a clinical review (2008) (78)
Impaired Lymphocyte Responsiveness in Inflammatory Bowel Disease (1973) (76)
Is Perianal Crohn's Disease Associated with Intestinal Fistulization? (2005) (75)
The Nature of Inflammatory Bowel Disease in Patients With Coexistent Colonic Diverticulosis (2006) (71)
Mycobacterial aetiology of Crohn's disease: serologic study using common mycobacterial antigens and a species-specific glycolipid antigen from Mycobacterium paratuberculosis. (1986) (64)
Chlorpromazine jaundice; analysis of twenty-two cases. (1957) (62)
Uveitis (iritis) associated with ulcerative and granulomatous colitis. (1967) (58)
The fate of the rectal segment after diversion of the fecal stream in Crohn's disease: its implications for surgical management. (1985) (57)
Shingles during the course of treatment with 6-mercaptopurine for inflammatory bowel disease (1999) (57)
Prognosis for nonoperative management of small-bowel obstruction in Crohn's disease. (1983) (56)
Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease (2018) (56)
Growth retardation in children with ulcerative colitis: the effect of medical and surgical therapy. (1975) (55)
Proctitis after fecal diversion in Crohn's disease and its elimination with reanastomosis: implications for surgical management. Report of four cases. (1984) (52)
Response to drug therapy in Crohn's disease: evaluation by rectal biopsy and mucosal cell counts. (1984) (51)
Allergic reactions to 6-mercaptopurine during treatment of inflammatory bowel disease. (1999) (51)
Carcinoma of the intestinal tract in Crohn's disease: results of a survey conducted by the National Foundation for Ileitis and colitis. (1983) (51)
Narcotic dependence in inflammatory bowel disease. (1988) (48)
Evaluation of 22 genetic variants with Crohn's Disease risk in the Ashkenazi Jewish population: a case-control study (2011) (48)
Inflammatory bowel disease and immune thrombocytopenic purpura: is there a correlation? (1997) (44)
Toxic dilation of the colon in the course of ulcerative colitis. (1960) (44)
Regional ileitis complicating pregnancy. (1956) (43)
Management of bladder fistulas in Crohn's disease. (1989) (41)
Diffuse Alveolar Hemorrhage After Infliximab Treatment of Crohn's Disease (2004) (39)
The safety of corticosteroid therapy in Crohn's disease with an abdominal mass. (1991) (39)
Crohn's disease and acute leukocytoclastic vasculitis of skin. (1996) (39)
Rectal strictures in Crohn's disease and coexisting perirectal complications (2008) (38)
Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective (2016) (38)
Rectal mucosal dysplasia in Crohn's disease. (1990) (38)
Mucosal-cell counts in ulcerative and granulomatous colitis. (1975) (38)
Complications of Pregnancy and Child Development After Cessation of Treatment With 6-Mercaptopurine for Inflammatory Bowel Disease (2003) (37)
Clinical Characteristics of Familial Versus Sporadic Crohn's Disease Using the Vienna Classification (2002) (36)
Granulomatous colitis in children: a study of 25 cases and comparison with ulcerative colitis. (1968) (35)
Histological healing favors lower risk of colon carcinoma in extensive ulcerative colitis. (2014) (34)
The prognosis of ulcerative colitis with onset in childhood. I. The presteroid era. (1962) (34)
A Search for the Optimal Duration of Treatment with 6-Mercaptopurine for Ulcerative Colitis (2004) (33)
Clinical trials in ulcerative colitis: II. Historical review. (1988) (33)
Successful infliximab therapy for a duodenal stricture caused by Crohn's disease. (2005) (32)
THE INFLUENCE OF CORTICOTROPHIN AND ADRENAL STEROIDS OF THE COURSE OF ULCERATIVE COLITIS: A COMPARISON WITH THE PRESTEROID ERA. (1964) (32)
Considerations of surveillance, dysplasia, and carcinoma of the colon in the management of ulcerative colitis and Crohn's disease. (1990) (31)
Pancreatitis and duodenopancreatic reflux in Crohn's disease. Case report and review of the literature. (1988) (30)
Mucosal healing as an index of colitis activity: back to histological healing for future indices. (2010) (30)
Responses to drug therapy in ulcerative colitis (1976) (29)
Kaposi's sarcoma occurring in association with ulcerative colitis. (1987) (29)
Fate of the rectum and distal colon after subtotal colectomy for ulcerative colitis. (1969) (28)
Toxicity of infliximab in the course of treatment of Crohn’s disease (2006) (28)
Carcinoma Arising in Crohn's Disease Fistulae: Another Concern Warranting Another Type of Surveillance (1999) (27)
Red man syndrome and infliximab. (2003) (26)
Intravenous Corticotrophin vs. Hydrocortisone in the Treatment of Hospitalized Patients with Crohn's Disease: A Randomized Double-Blind Study and Follow-Up (1998) (25)
Clinical course, late results, and pathological nature of inflammatory disease of the colon initially sparing the rectum. (1967) (25)
Prognosis of lymphoma in patients following treatment with 6‐mercaptopurine/azathioprine for inflammatory bowel disease (2012) (25)
Responses to drug therapy in ulcerative colitis. Evaluation by rectal biopsy and histopathological changes. (1975) (24)
Desensitization to sulfasalazine after hypersensitivity reactions in patients with inflammatory bowel disease. (1984) (23)
Incidence of neoplasms in patients who develop sustained leukopenia during or after treatment with 6-mercaptopurine for inflammatory bowel disease. (2006) (23)
The role of sigmoidoscopy and rectal biopsy in diagnosis and management of inflammatory bowel disease: personal experience. (1988) (21)
Experience with Eudragit-S-coated mesalamine (Asacol) in inflammatory bowel disease. An open study. (1993) (20)
Methotrexate for Crohn's disease. (1995) (19)
Complications of Crohn's disease predisposing to dysplasia and cancer of the intestinal tract: considerations of a surveillance program. (1984) (19)
Shortcomings of the National Crohn's Disease Study: the exclusion of azathioprine without adequate trial. (1981) (19)
Influenza vaccinations: should they really be encouraged for IBD patients being treated with immunosuppressives? (2009) (19)
Choice of laxatives and colonoscopic preparation in pregnant patients from the viewpoint of obstetricians and gastroenterologists. (2007) (18)
Controversy on recurrent ileitis after ileostomy: background and speculation. (1973) (18)
Intravenous Corticotrophin vs. Hydrocortisone in the Treatment of Hospitalized Patients with Crohn's Disease: A Randomized Double‐Blind Study and Follow‐Up (1998) (17)
Expert opinion: experience with 6-mercaptopurine in the treatment of inflammatory bowel disease. (2013) (16)
Inflammatory bowel disease in pregnancy. (1992) (15)
Sigmoidoscopy and biopsy in surveillance for cancer in ulcerative colitis. (1986) (15)
A history of immunosuppressive drugs in the treatment of inflammatory bowel disease: origins at The Mount Sinai Hospital. (2000) (15)
Epidemiological Evidence for a Hereditary Component in Crohn’s Disease (1981) (14)
Obesity/Bariatric Surgery and Crohn’s Disease (2017) (14)
Significance of WBC differential when leukopenia is induced by 6-MP for IBD. (1997) (13)
Dilatation of the colon, a serious complication of ulcerative colitis. (1960) (13)
CASE REPORT: Prolonged Remission of Severe Crohn's Disease After Fever and Leukopenia Caused by 6-Mercaptopurine (2004) (13)
Perforated nongranulomatous appendicitis in the course of regional ileitis. (1973) (12)
Local operative treatment of anorectal Crohn's disease. (1982) (12)
The effect of 6-mercaptopurine on natural killer-cell activities in Crohn's disease (1985) (12)
Inflammatory bowel disease during pregnancy (2001) (11)
Differential diagnosis of ulcerative and granulomatous colitis by sigmoidoscopy, rectal biopsy and cell counts of rectal mucosa. (1974) (11)
When should we look for amebae in patients with inflammatory bowel disease? (1989) (11)
Colonic-duodenal fistula in Crohn's disease (1977) (11)
Long term therapy of ulcerative colitis with 6-mercaptopurine: A personal series (1972) (11)
Pregnancy, fertility, and inflammatory bowel disease. (1985) (10)
Death from Crohn's disease. Lessons from a personal experience. (1995) (10)
Anal skin tags: an overlooked indicator of Crohn's disease. (2010) (10)
Is Treatment with 6-Mercaptopurine for Colitis Associated with the Development of Colorectal Cancer? (2013) (10)
From Crohn to Crohn's disease: 1979 an epidemiologic study in New York City. (1979) (9)
A Prospective Open-label Trial of Remicade® in Patients With Severe Exacerbation of Crohn's Disease Requiring Hospitalization: A Comparison With Outcomes Previously Observed in Patients Receiving Intravenous Hydrocortisone (2007) (8)
The prognosis of ulcerative colitis with onset in childhood. II. The steroid era. (1962) (8)
High Incidence of Recurrent Crohn’s Disease Following Colectomy for Ulcerative Colitis Revealed with Long Follow-Up (2018) (7)
The effect of antiplatelet therapy in patients with inflammatory bowel disease. (2012) (7)
Immunosuppressive therapy for ulcerative colitis, ileitis, and granulomatous colitis. (1972) (7)
Duodenal Biopsy Cell Counts and Histopathology in Crohn’s Disease (1981) (6)
Continuing immunomodulators and biologic medications in pregnant IBD patients - sometimes con. (2007) (6)
Colchicine for persistent constipation after total abdominal colectomy with ileorectostomy for colonic inertia. (2001) (6)
Adrenocorticotropin-induced adrenal hemorrhage. (1991) (6)
Desensitization of patients with allergic reactions to immunosuppressives in the treatment of inflammatory bowel disease (2010) (6)
6MP for fathers with IBD at the time of conception: the value of a large clinical experience over unrelated controls (2000) (6)
Inflammatory bowel disease : experience and controversy (1982) (6)
Gastrointestinal amyloidosis; report of a case and review of the clinical and radiological aspects. (1956) (6)
Long term response of Crohn's disease to treatment with 6-mercaptopurine (1978) (6)
Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases (2022) (6)
Steroids may prevent leukopenia, interfering with response to IV azathioprine in treatment of Crohn's disease. (2000) (5)
The surgical treatment of ulcerative colitis in childhood — a study of 38 cases (1968) (5)
Therapy of inflammatory bowel disease, including use of immunosuppressive agents. (1980) (5)
Is there a predisposition to malignancy when leukopenia is sustained during 6-mercaptopurine treatment of inflammatory bowel disease? (2000) (5)
Pharmacotherapy of inflammatory bowel disease. Part 3. 6-Mercaptopurine. (1983) (5)
Long-term immunosuppressive therapy of ulcerative colitis (1973) (5)
The role of liquid diet in the management of small bowel Crohn's disease. (2000) (5)
An indicator of Crohn's disease activity. A need unfulfilled. (1986) (5)
6-Mercaptopurine/Azathioprine remains an important contributor in managing Crohn's disease. (2014) (4)
Anorectal Crohn's disease: surgical and medical management. (2000) (4)
Crohn's colitis versus ulcerative colitis: should surveillance for dysplasia and cancer differ? (2009) (4)
Uveitis occurring after colectomy and ileal-rectal sleeve anastomosis for ulcerative colitis (1984) (4)
Steroids for Crohn's disease--an appreciation and a vote of confidence. (2002) (4)
Successful Treatment of Crohn’s Disease with an Immunosuppressive Drug [6-Mercaptopurine] (1981) (4)
Gastrointestinal and hepatic complications in pregnancy (1986) (4)
Is there any remaining role for methotrexate for Crohn's disease? (2003) (4)
Segmental sigmoid polyposis as a colonoscopic indicator of an ileosigmoid fistula in Crohn's ileitis. (2015) (4)
Steroids May Prevent Leukopenia, Hastening Response to IV Azathioprine in Treatment of Crohn's Disease (2000) (4)
Antimetabolites in inflammatory bowel disease: long-term experience. (1990) (3)
Epidemiological and psychosocial aspects of inflammatory bowel disease with observations on children, families, and pregnancy. (1982) (3)
Inflammatory Bowel Disease Exacerbations After the Initiation of Aspirin and Clopidogrel (Plavix®) - A Retrospective Case Control Study: 1284 (2010) (3)
Pyoderma gangrenosum complicating Crohn's disease. (1977) (3)
Optimal duration of treatment with 6-mercaptopurine for ulcerative colitis (2000) (3)
Imparied lymphocyte responsiveness in inflammatory bowel disease. (1973) (3)
Studies in vitro of intestinal carbohydrate and protein absorption; a progress review. (1959) (3)
Roentgen findings in the colon in a hemophiliac with melena. (1956) (3)
INCREASED INCIDENCE OF NEOPLASMS IN PATIENTS WHO DEVELOP SUSTAINED LEUKOPENIA DURING OR AFTER TREATMENT WITH 6 MP FOR INFLAMMATORY BOWEL DISEASE: 777 (2004) (3)
More evidence of the failure of oral cyclosporine to maintain remission due to intravenous cyclosporine in IBD. (1999) (3)
Reply to selected summary: Dysplasia through the sigmoidoscope—Tunnel vision? (Gastroenterology 1987;92:263–5) (1987) (3)
Can we prevent the inevitable? The use of 6-mercaptopurine or mesalamine to prevent postoperative recurrence in patients with Crohn disease (2005) (3)
The treatment of ulcerative colitis with "immunosuppressive" drugs. (1981) (2)
Crohn's disease presenting as isolated jejunitis years after childhood colitis. (1993) (2)
What are the rules when treatment with 6-MP/AZA is started? (2008) (2)
The use of 6-mercaptopurine in adolescents with Crohn's disease. (1991) (2)
Ulcerative colitis and Crohn's disease of the colon: their postoperative course. (1977) (2)
Pregnancy and inflammatory bowel disease. (1982) (2)
Sa1138 Patients With Inflammatory Bowel Disease and a History of Cancer: The Risk of Cancer Following Exposure to Immunosuppression (2015) (2)
6-Mercaptopurine in Crohn's fistulas (1985) (2)
Management of iatrogenic perforation during colonoscopy in ulcerative colitis patients: a survey of gastroenterologists and colorectal surgeons (2018) (2)
Identification of indeterminate colitis using panca and ASCA (2000) (2)
Evidence for Crohn’s Disease As an Extensive Process (1982) (2)
Is the Crohn's Disease Activity Index outdated? Yes. Is it the gold standard that clinicians should use? No. (1999) (2)
Enduring Value of Thiopurines for Inflammatory Bowel Disease Therapy (2017) (2)
Consideration of Smoking in Patients with Crohn's Disease (1996) (2)
Further evidence that 6-MP taken by the father with IBD provides risk of congenital anomaly to the pregnancy (2001) (2)
Sequential Crohn’s Ileitis, Ileosigmoidal Fistula, Segmental Sigmoid Polyposis, and Sigmoid Stricture: The Natural History (2017) (2)
Cancer in inflammatory bowel disease (1993) (2)
The Management of Severe Ulcerative Colitis During the Third Trimester of Pregnancy (2015) (2)
Drug choice in preventing postoperative Crohn's disease. (1996) (2)
The Current Role of Immunosuppressives in the Treatment of Inflammatory Bowel Disease (1986) (2)
Postendoscopy syndrome: "the doctor never talked to me". (2001) (2)
Where do we stand on drug treatment for ulcerative colitis? (1992) (2)
Immunosuppressive therapy of inflammatory bowel disease: a historical perspective. (1995) (2)
Crohn's disease (2010) (2)
The physiology of intestinal absorption. (1957) (1)
Phenotypic concordance and time clustering of diagnosis in multiply affected ibd families : the IOIBD Multiplex Family Collaborative Project, phases I a II (2005) (1)
Segmental Sigmoid Polyposis as a Colonoscopic Indicator of an Ileo-Sigmoid Fistula (ISF) in Crohn’s Disease: A Newly Recognized Prognostic Entity: 1699 (2014) (1)
Incarceration of the colon in a hiatus hernia producing duodenal obstruction. (1959) (1)
A Harvard medical student chronicles his fatal illness: the story of Alfred S. Reinhart, 1907-1931. (1995) (1)
Management of Inflammatory Bowel Disease (1992) (1)
Onset of Crohnʼs Disease After Bariatric Surgery in 3 Patients: 996 (2010) (1)
Crohn's proctitis: a distinct entity. (2010) (1)
Clinical trials in ulcerative colitis: I. Personal observations. (1988) (1)
Carcinoma complicating ulcerative colitis (1980) (1)
The ileorectal and ileosigmoidal fistula in Crohn's disease: a clinical-radiological correlation. (1984) (1)
The Ileitis of Ulcerative Colitis. Why Is It Not Crohn's Disease? (2017) (1)
A history of immunosuppressive drugs in the treatment of inflammatory bowel disease: origins at the Mount Sinai Hospital. (1996) (1)
Perianal Skin Tags in Inflammatory Bowel Disease: 1098 (2006) (1)
Program for management of massive upper gastrointestinal hemorrhage (1961) (1)
Ulcerative duodenitis with ulcerative colitis: is it Crohn's disease or really ulcerative colitis? (2001) (1)
THE COURSE OF GROWTH RETARDATION IN CHILDREN WITH ULCERATIVE COLITIS (1974) (1)
IBD in families, pregnancy, and childhood. (1983) (1)
Role of Nonsteroidal Anti-Inflammatory Drugs in Exacerbation of Inflammatory Bowel Disease. (2016) (1)
A Program for Management of Ulcerative Colitis with Respect to Cancer (1982) (1)
Development of Biopharmaceutical Parenteral Dosage Forms (1997) (1)
Steroid Addiction in Ulcerative Colitis (1965) (1)
Short and long term toxicity to 6-mercaptopurine in the treatment of Crohn's disease and ulcerative colitis: an update (2000) (1)
The role of immunosuppressives. (1983) (1)
Intravenous Remicade outpatient treatment of Crohn's disease: a personal experience (2000) (1)
The Utility of Anti-TNF Therapy in Treating Clostridium difficile Infections in Inflammatory Bowel Disease: A Case Series: 674 (2015) (1)
Infliximab vs. Hydrocortisone for Crohnʼs Disease Patients Requiring Hospitalization: 802 (2005) (1)
Guidelines for training in gastroenterology. (1981) (1)
Protocol for management of massive upper gastrointestinal hemorrhage. (1962) (1)
Drug Trials in Inflammatory Bowel Diseases 1993-1995: A Survey Conducted by the IOIBD. (1996) (1)
Onset of Crohnʼs disease after bariatric surgery in 3 patients: P-27. (2011) (1)
Inclusion of rectal biopsies at colonoscopy (1988) (1)
COMMENTARY—OBSERVATIONS ON SULFASALAZINE IN CROHN'S DISEASE AND ULCERATIVE COLITIS (1987) (0)
Inside inflammatory bowel disease. (1975) (0)
Will Oral 5-ASA be the Answer to Postoperative Recurrence of Crohn's Disease? (1995) (0)
6-mp and azathioprine for Crohn's disease: how long do you keep a good thing going? (1997) (0)
THE NATURE OF INFLAMMATORY BOWEL DISEASE (IBD) IN PATIENTS WITH COEXISTENT COLONIC DIVERTICULOSIS: 778 (2004) (0)
Recommendations for New Trials of Currently Available Therapy by the IOIBD Task Force on Clinical Trials* (1995) (0)
Low Grade Dysplasia Preceding Neoplasia in Inflammatory Bowel Disease: 1154 (2005) (0)
Small and Large Bowel Disease in Pregnancy (1985) (0)
The authors reply (1999) (0)
Gastrointestinal and hepatic complications in pregnancy: Edited by V. K. Rustgi and J. N. Cooper. 292 pp., $39.95. John Wiley & Sons, New York, New York, 1986 (1986) (0)
Letter to the editor6MP for fathers with IBD at the time of conception: the value of a large clinical experience over unrelated controls (2000) (0)
Recurrence Rates After Surgery for Crohn’s Disease and Their Implications Regarding Indications for Surgery (As Seen by the Gastroenterologist) (1982) (0)
Corticosteroid and Biologic Use Not Associated With Adverse Outcomes for Inflammatory Bowel Disease Patients Hospitalized With COVID-19 (2021) (0)
for therapy or for prophylaxis, and perhaps it will soon be common- Drug Choice in Preventing Postoperative place for them to be used in unison. (1996) (0)
ROLE OF APPENDECTOMY IN THE CLINICAL COURSE OF CROHNʼS DISEASE: 805 (2004) (0)
ABNORMALITIES OF THE UTERINE CERVIX IN WOMEN WITH IBD: 833 (2004) (0)
Sheldon C. Sommers, M.D. (2003) (0)
The Changing Prognosis of Ulcerative Colitis and Crohn Disease by Decades (2021) (0)
prine should be reduced in stages starting long in ad- vance of its termination. (1997) (0)
Prognosis for Lymphoma in Patients with Inflammatory Bowel Disease Treated with 6-mercaptopurine or Azathioprine: 1145 (2010) (0)
Shedding light on the isotretinoin and Inflammatory Bowel Disease relationship: A case series of 7 patients: P-28. (2011) (0)
ULCERATIVE COLITIS IN CHILDREN. (1964) (0)
Prognosis of granulomatous colitis with onset in childhood. (1968) (0)
Inflammatory bowel disease: a comparison of demographic and clinical characteristics between caucasians and ethnic minorities (2003) (0)
A Search for the Best Utilization of Serum Infliximab (IFX) and Antibodies to Infliximab (ATI) Levels in Patients With Inflammatory Bowel Disease: 1659 (2014) (0)
Full Potential of 6-Mercaptopurine in IBD May Remain Untapped. (2020) (0)
Chapter 43 – Ulcerative Colitis (2010) (0)
Guidelines for subspecialty training in gastroenterology: The clinician's perspective (1981) (0)
My thoughts on using cyclosporine in the treatment of inflammatory bowel disease. (1995) (0)
General Discussion and Conclusions on certain topics of the treatment (1981) (0)
A PROSPECTIVE, OPEN-LABEL TRIAL OF INFLIXIMAB IN PATIENTS WITH CROHNʼS DISEASE REQUIRING HOSPITALIZATION: 803 (2004) (0)
The Management of IBD With Biologics in the Third Trimester of Pregnancy: 1510 (2014) (0)
New developments in the field of ileitis and colitis. (1980) (0)
Tu1126 Histological Healing Is Associated With a Decreased Risk of Colon Cancer in Cases of Longstanding Universal Ulcerative Colitis (2013) (0)
Physician Practices: Management of Perforation in Ulcerative Colitis: 674 (2016) (0)
The authors reply (1999) (0)
Colonic and inflammatory bowel diseases. (1975) (0)
Rectal Strictures in Crohnʼs Disease and Co-Existing Perirectal Complications: 1175 (2006) (0)
Increasing Pediatricians’ Awareness of the Association between Anal Skin Tags and Earlier Diagnosis of Crohn’s Disease (2018) (0)
P-082 YouTube: A Questionable Source of Information for Information for Patients with Inflammatory Bowel Disease (2017) (0)
Shedding Light on the Isotretinoin and Inflammatory Bowel Disease Relationship: A Case Series of 7 Patients: 972 (2011) (0)
What is Considered Good Medical Care In Crohn’s Disease? (1982) (0)
Letter to the editorFurther evidence that 6-MP taken by the father with IBD provides risk of congenital anomaly to the pregnancy (2001) (0)
Obituary for William Modell (2008) (0)

This paper list is powered by the following services:

Burton I. Korelitz's Academic­Influence.com Rankings

Burton I. Korelitz's Degrees

Why Is Burton I. Korelitz Influential?

Burton I. Korelitz's Published Works

Published Works

Burton I. Korelitz's AcademicInfluence.com Rankings